No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment

To study the differences in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding (EVB) and renal functional impairment (RFI). METHODS: The National Health Insurance Database, part of the Taiwan National Health Insurance Program, was used...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur J Gastroenterol Hepatol
Egile Nagusiak: Hung, Tsung-Hsing, Tsai, Chen-Chi, Tseng, Chih-Wei, Tseng, Kuo-Chih, Hsieh, Yu-Hsi, Tsai, Chih-Chun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams And Wilkins 2016
Gaiak:
Original Articles: Liver Failure
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5051540/
https://ncbi.nlm.nih.gov/pubmed/27455080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MEG.0000000000000703
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak